Concepedia

Amol D. Dhamane

AD

24

Publications

952

Citations

18

H-Index

2012

Active since

Affiliations

Pfizer (United States)(Current)

Bristol-Myers Squibb (United States)

New York City College of Technology

City University of New York

STATinMED (United States)

Amol D. Dhamane is an author at Pfizer (United States) specializing in pharmacotherapy, medicine, and cardiovascular disease.

Top concepts

Publications per year

2012–2021

24

Publications

24

Short-acting β-agonist use and its ability to predict future asthma-related outcomes

Richard H. Stanford, Manan Shah, Anna O. D’Souza et al. · Annals of Allergy Asthma & Immunology · 2012 · 183 citations

, , +6

COPD exacerbation frequency and its association with health care resource utilization and costs

Amol D. Dhamane, Chad Moretz, Yunping Zhou et al. · International Journal of COPD · 2015 · 98 citations · Full text

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

Phil Schwab, Amol D. Dhamane, Sari Hopson et al. · International Journal of COPD · 2017 · 65 citations · Full text

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding

Gregory Y.H. Lip, Allison Keshishian, Yan Zhang et al. · JAMA Network Open · 2021 · 54 citations · Full text

Comparisons between Oral Anticoagulants among Older Nonvalvular Atrial Fibrillation Patients

Steven Deitelzweig, Allison Keshishian, Xiaoyan Li et al. · Journal of the American Geriatrics Society · 2019 · 52 citations · Full text

Rows per page

1–5 of 24